Sign in

CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
  1. 4 Grant or award President and CEO acquired 250,000 shares (grant or award)
  2. SC 13G Stake Amended Statement of Ownership
  3. 8-K Event Other events
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 8-K Event Executive or director change
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 4 Open-market buy President and CEO bought 20,000 shares at $5.10 ($101,908)
  14. 8-K Event Regulation FD disclosure · Other events
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations · Other events
  17. 8-K Event Regulation FD disclosure · Other events
  18. 4 Open-market buy President and CEO bought 8,710 shares at $5.68 ($49,483)
  19. SC 13G Stake Amended Statement of Ownership
  20. 4 Open-market buy President and CEO bought 8,680 shares at $5.81 ($50,433)

Page 16 of 33 · 650 filings